Presence of Akkermansiaceae in gut microbiome and immunotherapy effectiveness in patients with advanced non-small cell lung cancer

Presence of Akkermansiaceae in gut microbiome and immunotherapy effectiveness in patients with advanced non-small cell lung cancer

The significance of Akkermansia bacteria presence in gut micobiome, mainly Akkermansia mucinifila, is currently being investigated in the context of supporting therapy and marker for response to immunotherapy in cancer patients. It is indicated that patients with non-small cell lung cancer (NSCLC) t...

Full description

Bibliographic Details
Main Authors: Bomba, A. (Author), Chmielewska, I. (Author), Frąk, M. (Author), Giza, A. (Author), Grenda, A. (Author), Iwan, E. (Author), Jarosz, B. (Author), Kieszko, R. (Author), Krawczyk, P. (Author), Kucharczyk, T. (Author), Milanowski, J. (Author), Rolska, A. (Author), Szczyrek, M. (Author), Wasyl, D. (Author)
Format: Article
Language:English
Published: Springer Science and Business Media Deutschland GmbH 2022
Subjects:
Akkermansiaceae
Microbiome
NSCLC
PD-1
PD-L1
Response to immunotherapy
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items